Does ENASIDENIB Cause Decreased appetite? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Decreased appetite have been filed in association with ENASIDENIB (Idhifa). This represents 3.3% of all adverse event reports for ENASIDENIB.
122
Reports of Decreased appetite with ENASIDENIB
3.3%
of all ENASIDENIB reports
3
Deaths
35
Hospitalizations
How Dangerous Is Decreased appetite From ENASIDENIB?
Of the 122 reports, 3 (2.5%) resulted in death, 35 (28.7%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ENASIDENIB.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Platelet count decreased (113)
Drug ineffective (108)
Differentiation syndrome (102)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ENASIDENIB Alternatives Have Lower Decreased appetite Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ